Literature DB >> 7186227

Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortality.

J J Sayen, R B Singer, G Peirce, O Horwitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 7186227      PMCID： PMC2279570     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  26 in total

1.  The effect of heparin on oxygen transport from blood to tissues.

Authors:  H Engleberg
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

2.  Initial myocardial infarction among 503 veterans: five-year survival.

Authors:  O W BEARD; H R HIPP; M ROBINS; J S TAYLOR; R V EBERT; L G BERAN
Journal:  Am J Med       Date:  1960-06       Impact factor: 4.965

3.  The observation of heparin on endothelium after injection.

Authors:  L M Hiebert; L B Jaques
Journal:  Thromb Res       Date:  1976-02       Impact factor: 3.944

4.  Immediate and long-term prognosis of acute myocardial infarction in the aged.

Authors:  G Librach; M Schadel; M Seltzer; A Hart; N Yellin
Journal:  J Chronic Dis       Date:  1976-08

5.  Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters.

Authors:  E Weinblatt; S Shapiro; C W Frank; R V Sager
Journal:  Am J Public Health Nations Health       Date:  1968-08

6.  Highly active heparin species with multiple binding sites for antithrombin.

Authors:  R D Rosenberg; R E Jordan; L V Favreau; L H Lam
Journal:  Biochem Biophys Res Commun       Date:  1979-02-28       Impact factor: 3.575

Review 7.  Heparin, antithrombin, and abnormal clotting.

Authors:  R D Rosenberg
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

8.  Additional data favoring use of anticoagulant therapy in myocardial infarction. A population-based study.

Authors:  M Szklo; J A Tonascia; R Goldberg; H L Kennedy
Journal:  JAMA       Date:  1979-09-21       Impact factor: 56.272

9.  Prognosis of women with newly diagnosed coronary heart disease--a comparison with course of disease among men.

Authors:  E Weinblatt; S Shapiro; C W Frank
Journal:  Am J Public Health       Date:  1973-07       Impact factor: 9.308

10.  The antithrombotic effects of warfarin and heparin following infusions of tissue thromboplastin in rabbits: clinical implications.

Authors:  S N Gitel; S Wessler
Journal:  J Lab Clin Med       Date:  1979-09
View more
  3 in total

1.  Heparin for oral use: preliminary studies.

Authors:  O Horwitz; W T Johnson; J J Sayen; B Roberts; A F Whereat
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

Review 2.  Heparin versus placebo for non-ST elevation acute coronary syndromes.

Authors:  Carlos A Andrade-Castellanos; Luis E Colunga-Lozano; Netzahualpilli Delgado-Figueroa; Kirk Magee
Journal:  Cochrane Database Syst Rev       Date:  2014-06-27

3.  Heparan sulfate proteoglycans present PCSK9 to the LDL receptor.

Authors:  Camilla Gustafsen; Ditte Olsen; Joachim Vilstrup; Signe Lund; Anika Reinhardt; Niels Wellner; Torben Larsen; Christian B F Andersen; Kathrin Weyer; Jin-Ping Li; Peter H Seeberger; Søren Thirup; Peder Madsen; Simon Glerup
Journal:  Nat Commun       Date:  2017-09-11       Impact factor: 14.919
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.